NinePointTwo Capital LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 188 filers reported holding FATE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 4.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
NinePointTwo Capital LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$281
+121.3%
49,325
+291.6%
0.11%
+100.0%
Q4 2022$12712,5960.05%
Other shareholders
FATE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 716,392$11,126,00012.18%
Polaris Venture Management Co. V, L.L.C. 1,139,783$17,701,00010.06%
Grosvenor Holdings, L.L.C. 2,285,714$35,497,0006.41%
Redmile Group, LLC 11,216,809$174,197,0005.83%
Casdin Capital, LLC 2,550,000$39,601,500,0004.10%
DAFNA Capital Management LLC 470,000$7,299,0002.74%
Ghost Tree Capital, LLC 350,000$5,436,0001.38%
Artal Group S.A. 2,000,000$31,060,0001.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,952,897$30,328,0001.24%
Copernicus Capital Management, LLC 75,000$1,165,0001.08%
View complete list of FATE THERAPEUTICS INC shareholders